This suggested that the changing trend of IL-1β was opposite to that of depression and anxiety symptoms, indicating that the change of IL-1β could reflect the curative effect to a certain extent in MDD patients with effective antidepressant treatment. The gene discussed is IL1B; the disease is major depressive disorder.